
Few & Far Between: Conversations from the Front Lines of Drug Development Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
Oct 23, 2024
Chapters
Transcript
Episode notes

Few & Far Between: Conversations from the Front Lines of Drug Development